Dr. Reddy's Laboratories Limited (FRA:RDDA)

Dr. Reddy's Laboratories Revenue

Dr. Reddy's Laboratories had revenue of 88.28B INR in the quarter ending September 30, 2025, with 9.83% growth. This brings the company's revenue in the last twelve months to 343.10B, up 14.13% year-over-year. In the fiscal year ending March 31, 2025, Dr. Reddy's Laboratories had annual revenue of 325.54B with 16.61% growth.

• Revenue (ttm): 343.10B INR
• Revenue Growth: +14.13%
• P/S Ratio: 3.07
• Revenue / Employee: 12.34M INR
• Employees: 27,811
• Market Cap: 10.07B EUR

Revenue Chart

* This company reports financials in INR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	325.54B	46.37B	16.61%
Mar 31, 2024	279.16B	33.29B	13.54%
Mar 31, 2023	245.88B	31.49B	14.69%
Mar 31, 2022	214.39B	24.67B	13.00%
Mar 31, 2021	189.72B	15.12B	8.66%
Mar 31, 2020	174.60B	20.75B	13.49%
Mar 31, 2019	153.85B	11.82B	8.32%
Mar 31, 2018	142.03B	1.22B	0.87%
Mar 31, 2017	140.81B	-13.90B	-8.98%
Mar 31, 2016	154.71B	6.52B	4.40%
Mar 31, 2015	148.19B	16.02B	12.12%
Mar 31, 2014	132.17B	15.90B	13.68%
Mar 31, 2013	116.27B	19.53B	20.19%
Mar 31, 2012	96.74B	22.04B	29.51%
Mar 31, 2011	74.69B	4.42B	6.28%
Mar 31, 2010	70.28B	836.00M	1.20%
Mar 31, 2009	69.44B	19.44B	38.87%
Mar 31, 2008	50.01B	-15.09B	-23.18%
Mar 31, 2007	65.10B	40.83B	168.24%
Mar 31, 2006	24.27B	4.75B	24.32%
Mar 31, 2005	19.52B	-	-